GS-441524 is a nucleoside analogue antiviral drug which was developed by Gilead Sciences. It is the main plasma metabolite of the antiviral prodrug remdesivir...
22 KB (2,197 words) - 16:56, 17 June 2024
other biological processes in the FIP virus. An experimental drug called GS-441524 was used in a field experiment of 31 cats. After 25 days, five cats had...
26 KB (2,878 words) - 20:13, 28 August 2024
Remdesivir (redirect from GS-5734)
intended to allow intracellular delivery of GS-441524 monophosphate and subsequent biotransformation into GS-441524 triphosphate, a ribonucleotide analogue...
114 KB (9,889 words) - 16:36, 27 September 2024
Obeldesivir (redirect from GS-5245)
Obeldesivir (GS-5245, ATV006) is an isobutyric ester prodrug of GS-441524 made by Gilead Sciences that is currently in Phase III trials for the outpatient...
7 KB (526 words) - 18:56, 30 April 2024
Victoria C.; Muller, Florian L. (2020). "Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment". ACS Medicinal Chemistry Letters...
7 KB (858 words) - 17:05, 6 July 2024
which treatment is generally symptomatic and palliative only. The drug GS-441524 shows promise as an antiviral treatment for FIP, but at the moment it...
31 KB (3,348 words) - 04:56, 15 July 2024
Gilead Sciences and remdesivir, and the potentially cheaper alternative GS-441524. In 1968, Nader recruited seven volunteer law students, dubbed "Nader's...
8 KB (592 words) - 22:24, 20 September 2024
against Hepatitis C and remdesivir, an FDA approved drug against COVID- GS-441524 triphosphate is a substrate for RdRp, but not mammalian polymerases. It...
27 KB (3,099 words) - 15:01, 25 June 2024
hydrobromide salt of this drug. The drug is a deuterated tri-isobutyrate of GS-441524, the active metabolite of remdesivir. It was first described in a November...
5 KB (481 words) - 07:29, 14 August 2024
(self-immolation is the key principle of ProTide nucleotide prodrugs). Because GS-441524 nucleoside can be phosphorylated and activated, some researchers have...
11 KB (1,362 words) - 16:12, 10 June 2024